It is all part of a unique Kentucky-based program funded through coal severance dollars that brings new computers to local schools and also uses those same computers to provide vast computing resources to Kentucky universities to fight deadly diseases. Winters, Henley and Tilley were instrumental in pushing the legislation for Kentucky schools.
Since the program was introduced almost four years ago, over 10,000 computers have been placed in Kentucky schools, and five potential drugs have been moved into development.
“While we are still several steps away and potentially many years away from having approved cancer treatments, this is an exciting milestone in the overall process,” Winters said.
“More importantly, this program enables groups to share resources so that the state is able to extend computer capabilities further than if each tried to purchaase and use the equipment on their own,” Tilley said.
“For ever dollar we invest, local students are getting the latest education technology, university researchers get the tools they need to make life-saving discoveries, and we create new products that fuel Kentucky-based companies,” Tilley said.
With 52 school districts, three companies and two universities working together, the program succeeds on a statewide network. Advanced Cancer Therapeutics, LLC, which is partially owned by the University of Louisville, was created to advance preclinical anti-cancer discoveries from the James Graham Brown Cancer Center to human clinical trials, which may then be licensed to leading pharmaceutical companies for late-stage development and commercialization. Morehead State University established its 21st Century Education Enterprise to support education needs of participating schools. Dataseam, a Kentucky-based not-for-profit company, created the program, manages the computers and works with the local schools and universities.
“We are extremely excited about the discovery of our fifth cancer drug developed through the partnership with the General Assembly, Dataseam and Advanced Cancer Therapeutics, LLC,” said James Ramsey, President of the University of Louisville. “Notonly are we one step closer to finding a cure for cancer, but we are enriching the lives of students across the Commonwealth.”
“We have a lot of talented people in our state, which makes this an amazingly successful partnership,” said Brian Gupton, Dateseam CEO. “We look forward to what the diverse organizations and talented individuals in our state will do next with this program.”
(This press release was submitted by Terry Lindsey, Dataseam.)